AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis, B. D.
Right arrow Articles by Goellner, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, B. D.
Right arrow Articles by Goellner, J. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Percutaneous Ethanol Injection for Treatment of Cervical Lymph Node Metastases in Patients with Papillary Thyroid Carcinoma

B. D. Lewis1, I. D. Hay2, J. W. Charboneau1, B. McIver2, C. C. Reading1 and J. R. Goellner3

1 Department of Radiology, Mayo Clinic and Mayo Foundation, 200 First St., SW, Rochester, MN 55905.
2 Division of Endocrinology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN 55905.
3 Department of Surgical Pathology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905.



View larger version (142K):

[in a new window]
 
Fig. 1A. Transverse sonograms of metastatic adenopathy in 48-year-old woman with papillary thyroid carcinoma. Sonogram reveals 8 x 9 mm lymph node (arrow) with needle in place.

 


View larger version (138K):

[in a new window]
 
Fig. 1B. Transverse sonograms of metastatic adenopathy in 48-year-old woman with papillary thyroid carcinoma. Image obtained at initial injection with small volume of ethanol shows echogenic region in posterior aspect of lymph node (arrowhead) due to microbubble formation.

 


View larger version (136K):

[in a new window]
 
Fig. 1C. Transverse sonograms of metastatic adenopathy in 48-year-old woman with papillary thyroid carcinoma. Image obtained after repositioning of needle shows another site in lymph node (arrow) being treated.

 


View larger version (151K):

[in a new window]
 
Fig. 1D. Transverse sonograms of metastatic adenopathy in 48-year-old woman with papillary thyroid carcinoma. Image obtained 9 months after percutaneous ethanol injection shows that size of treated lymph node (cursors) has decreased markedly.

 


View larger version (27K):

[in a new window]
 
Fig. 2A. 27-year-old woman with papillary thyroid carcinoma. Standard diagram used to map location of each lymph node (to facilitate follow-up and communication between sonographic examinations) shows several left internal jugular nodes were identified, with one node (arrow) located between internal jugular vein and common carotid artery. SMG = submandibular gland.

 


View larger version (149K):

[in a new window]
 
Fig. 2B. 27-year-old woman with papillary thyroid carcinoma. Corresponding transverse sonogram reveals lymph node (cursors). CCA = common carotid artery, JUG = internal jugular vein.

 


View larger version (158K):

[in a new window]
 
Fig. 3A. Favorable response to percutaneous ethanol injection in 55-year-old woman with papillary thyroid carcinoma. Longitudinal sonogram shows 4 x 7 x 7 mm lymph node (cursors) that was positive for metastatic papillary thyroid carcinoma at biopsy.

 


View larger version (103K):

[in a new window]
 
Fig. 3B. Favorable response to percutaneous ethanol injection in 55-year-old woman with papillary thyroid carcinoma. Power Doppler sonogram shows marked nodal perfusion.

 


View larger version (176K):

[in a new window]
 
Fig. 3C. Favorable response to percutaneous ethanol injection in 55-year-old woman with papillary thyroid carcinoma. Longitudinal sonogram obtained 9 months after percutaneous ethanol injection shows size of lymph node (cursors) has decreased dramatically to 2 x 2 x 5 mm, and there is no color Doppler sonographic evidence of perfusion.

 


View larger version (11K):

[in a new window]
 
Fig. 4. Graph shows mean volume in cubic millimeters in metastatic lymph nodes treated with percutaneous ethanol ablation over time.

 


View larger version (112K):

[in a new window]
 
Fig. 5A. Persistent perfusion after initial percutaneous ethanol injection requiring retreatment in 36-year-old man with papillary thyroid carcinoma. Longitudinal sonogram shows enlarged biopsy-confirmed metastatic lymph node (cursors).

 


View larger version (148K):

[in a new window]
 
Fig. 5B. Persistent perfusion after initial percutaneous ethanol injection requiring retreatment in 36-year-old man with papillary thyroid carcinoma. Power Doppler sonogram reveals uniform perfusion before percutaneous ethanol injection.

 


View larger version (134K):

[in a new window]
 
Fig. 5C. Persistent perfusion after initial percutaneous ethanol injection requiring retreatment in 36-year-old man with papillary thyroid carcinoma. Longitudinal sonogram obtained 9 weeks after percutaneous ethanol injection shows size of lymph node is unchanged, and there is evidence of slight residual perfusion. Because of these findings, percutaneous ethanol injection treatment was repeated.

 


View larger version (136K):

[in a new window]
 
Fig. 5D. Persistent perfusion after initial percutaneous ethanol injection requiring retreatment in 36-year-old man with papillary thyroid carcinoma. Longitudinal sonogram obtained 14 weeks after C reveals that size of lymph node (arrows) has decreased dramatically. No perfusion on power Doppler sonography is shown.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Roentgen Ray Society.